| ID: 129933208 | ATAC-STARR-seq lymphoblastoid active region 15388 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20424840..20424999) | | |
| ID: 129933207 | ATAC-STARR-seq lymphoblastoid active region 15386 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20334145..20334204) | | |
| ID: 127272748 | H3K4me1 hESC enhancer GRCh37_chr2:20621954-20622467 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20422193..20422706) | | |
| ID: 127272747 | NANOG-H3K4me1 hESC enhancer GRCh37_chr2:20581046-20581877 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20381285..20382116) | | |
| ID: 127272746 | H3K27ac hESC enhancer GRCh37_chr2:20551335-20551964 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20351574..20352203) | | |
| ID: 127272744 | H3K27ac hESC enhancers GRCh37_chr2:20550073-20550702 and GRCh37_chr2:20550703-20551334 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20350227..20351573) | | |
| ID: 120961743 | Sharpr-MPRA regulatory region 5478 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20411488..20411782) | | |
| ID: 106479068 | RNA, U7 small nuclear 113 pseudogene [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20246326..20246387, complement) | | |
| ID: 105373465 | uncharacterized LOC105373465 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20403191..20424945, complement) | | |
| ID: 100873319 | RNA, 5S ribosomal pseudogene 86 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20401627..20401724, complement) | RN5S86 | |
| ID: 100421404 | RP9, pre-mRNA splicing factor pseudogene [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20291539..20292262, complement) | | |
| ID: 100289450 | solute carrier family 7 member 15, pseudogene [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20386386..20396585) | ARPAT | |
| ID: 23369 | pumilio RNA binding family member 2 [Homo sapiens (human)] | Chromosome 2, NC_000002.12 (20248691..20352253, complement) | PUMH2, PUML2 | 607205 |